Dosis de enoxaparina asociada a disminución de riesgo de muerte en COVID-19

BACKGROUND: In December 2019, an outbreak of COVID-19 was reported for the first time. This disease has caused millions of deaths worldwide. To date multiple drugs have been tried, without finding an effective treatment yet. OBJECTIVE: To describe the evolution and the pharmacological treatment used...

Descripción completa

Detalles Bibliográficos
Autores principales: Joanico-Morales, Baltazar, Gaspar-Chamu, Alma Delia, Salgado-Jiménez, María de los Ángeles, Rodríguez-Echeverría, Gabriela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Mexicano del Seguro Social 2022
Materias:
Aportación Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396039/
https://www.ncbi.nlm.nih.gov/pubmed/35271222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396039/
https://www.ncbi.nlm.nih.gov/pubmed/35271222

Ejemplares similares